A Critical Review of the Risks and Benefits of New Therapies

Open Access
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Michael A. Nauck

Diabetes Care Jul 2013, 36 (7) 2126-2132; DOI: 10.2337/dc12-2504
Open Access
A Critical Analysis of the Clinical Use of Incretin-Based Therapies
Peter C. Butler, Michael Elashoff, Robert Elashoff, Edwin A.M. Gale

Diabetes Care Jul 2013, 36 (7) 2118-2125; DOI: 10.2337/dc12-2713
Open Access
Interpreting Adverse Signals in Diabetes Drug Development Programs
Clifford J. Bailey

Diabetes Care Jul 2013, 36 (7) 2098-2106; DOI: 10.2337/dc13-0182
Open Access
Assessing the Benefit-Risk for New Drugs
Eric P. Brass

Diabetes Care Jul 2013, 36 (7) 1823-1826; DOI: 10.2337/dc13-0891
Open Access
Signals and Noise in Drug Safety Analyses
William T. Cefalu, Julio Rosenstock, Robert R. Henry, Matthew Riddle

Diabetes Care Jul 2013, 36 (7) 1804-1806; DOI: 10.2337/dc13-0895

Main menu